Divergent SATB1 expression across human life span and tissue compartments

SATB1 Defines a Subtype of Cutaneous CD30 + Lymphoproliferative Disorders Associated with a T-Helper 17 Cytokine Profile

(2018) Jingru Sun et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

SATB1 in Malignant T Cells

(2018) Simon Fredholm et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

SATB1 Is a Pivotal Epigenetic Biomarker in Cutaneous T-Cell Lymphomas

(2018) Sandrine Poglio et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Single-Cell Approach to Influenza-Specific CD8+ T Cell Receptor Repertoires Across Different Age Groups, Tissues, and Following Influenza Virus Infection

(2018) Sneha Sant et al.   Frontiers in Immunology

Complimentary mechanisms of dual checkpoint blockade expand unique T-cell repertoires and activate adaptive anti-tumor immunity in triple-negative breast tumors

(2018) Erika J. Crosby et al.   OncoImmunology

SATB1 Expression Governs Epigenetic Repression of PD-1 in Tumor-Reactive T Cells

(2017) Tom L. Stephen et al.   IMMUNITY

Cancer therapies in HIV cure research

(2017) Thomas A. Rasmussen et al.   Current Opinion in HIV and AIDS

Maintenance of the EBV-specific CD8+ TCRαβ repertoire in immunosuppressed lung transplant recipients

(2016) Thi HO Nguyen et al.   IMMUNOLOGY AND CELL BIOLOGY

Regulation of SATB1 during thymocyte development by TCR signaling

(2016) Kamalvishnu P. Gottimukkala et al.   MOLECULAR IMMUNOLOGY

Molecular basis for universal HLA-A*0201–restricted CD8+T-cell immunity against influenza viruses

(2016) Sophie A. Valkenburg et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations

(2016) Weiping Zou et al.   Science Translational Medicine

The Next Immune-Checkpoint Inhibitors: PD-1/PD-L1 Blockade in Melanoma

(2015) Kathleen M. Mahoney et al.   CLINICAL THERAPEUTICS

Expression of SATB1 and HER2 in breast cancer and the correlations with clinicopathologic characteristics

(2015) Xiangdong Liu et al.   Diagnostic Pathology

SATB1 Promotes Pancreatic Cancer Growth and Invasion Depending on MYC Activation

(2015) Zheng Chen et al.   DIGESTIVE DISEASES AND SCIENCES

Divergent expression patterns of SATB1 mRNA and SATB1 protein in colorectal cancer and normal tissues

(2015) Anna E. Kowalczyk et al.   TUMOR BIOLOGY

Survival, Durable Tumor Remission, and Long-Term Safety in Patients With Advanced Melanoma Receiving Nivolumab

(2014) Suzanne L. Topalian et al.   JOURNAL OF CLINICAL ONCOLOGY

NFATc1 Regulates PD-1 Expression upon T Cell Activation

(2014) K. J. Oestreich et al.   JOURNAL OF IMMUNOLOGY

Expression of SATB1 Promotes the Growth and Metastasis of Colorectal Cancer

(2014) Yi Zhang et al.   PLoS One

Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma

(2013) Omid Hamid et al.   NEW ENGLAND JOURNAL OF MEDICINE

Upregulation of SATB1 Is Associated with Prostate Cancer Aggressiveness and Disease Progression

(2013) Sanjeev Shukla et al.   PLoS One

Repression of the genome organizer SATB1 in regulatory T cells is required for suppressive function and inhibition of effector differentiation

(2011) Marc Beyer et al.   NATURE IMMUNOLOGY

SATB1 dictates expression of multiple genes including IL-5 involved in human T helper cell differentiation

(2010) H. Ahlfors et al.   BLOOD

Phase I Study of Single-Agent Anti–Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates

(2010) Julie R. Brahmer et al.   JOURNAL OF CLINICAL ONCOLOGY

Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity

(2010) Kaori Sakuishi et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection

(2008) Shawn D Blackburn et al.   NATURE IMMUNOLOGY